We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+1.26%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$6.28B
AUM Growth
-$59.5M
Cap. Flow
-$78.7M
Cap. Flow %
-1.25%
Top 10 Hldgs %
28.49%
Holding
498
New
72
Increased
148
Reduced
175
Closed
71

Sector Composition

Rank Sector Weight
1 Energy 51.06%
2 Financials 8.91%
3 Industrials 7.34%
4 Consumer Discretionary 5.31%
5 Technology 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVH icon
426
Evolent Health
EVH
$475M
-86,739
Closed -$2.2M
EXEL icon
427
Exelixis
EXEL
$13.9B
-58,609
Closed -$1.44M
FICO icon
428
Fair Isaac
FICO
$28.7B
-11,296
Closed -$1.57M
FUL icon
429
H.B. Fuller
FUL
$3B
-354,422
Closed -$18.1M
GCBC icon
430
Greene County Bancorp
GCBC
$562M
-15,628
Closed -$213K
GE icon
431
GE Aerospace
GE
$367B
-4,257
Closed -$551K
GT icon
432
Goodyear
GT
$2.07B
-6,099
Closed -$213K
HONE
433
DELISTED
HarborOne Bancorp
HONE
-57,196
Closed -$636K
INCY icon
434
Incyte
INCY
$23.5B
-11,643
Closed -$1.47M
IONS icon
435
Ionis Pharmaceuticals
IONS
$9.35B
-12,469
Closed -$634K
IRWD icon
436
Ironwood Pharmaceuticals
IRWD
$611M
-57,815
Closed -$914K
ISRG icon
437
Intuitive Surgical
ISRG
$121B
-12,924
Closed -$1.34M
LAZ icon
438
Lazard
LAZ
$4.37B
-27,117
Closed -$1.26M
LRFC
439
DELISTED
Logan Ridge Finance Corp
LRFC
-57,718
Closed -$4.5M
LXRX icon
440
Lexicon Pharmaceuticals
LXRX
$1.02B
-74,907
Closed -$1.23M
LYG icon
441
Lloyds Banking Group
LYG
$87.4B
-20,853
Closed -$74K
MCK icon
442
McKesson
MCK
$98.5B
-1,220
Closed -$201K
MDXG icon
443
MiMedx Group
MDXG
$626M
-44,225
Closed -$662K
MRK icon
444
Merck
MRK
$324B
-3,384
Closed -$207K
MXL icon
445
MaxLinear
MXL
$6.41B
-70,809
Closed -$1.98M
NDSN icon
446
Nordson
NDSN
$16.5B
-9,831
Closed -$1.19M
PLAY icon
447
Dave & Buster's
PLAY
$343M
-45,119
Closed -$3M
QCOM icon
448
Qualcomm
QCOM
$176B
-7,793
Closed -$430K
SAGE
449
DELISTED
Sage Therapeutics
SAGE
-5,975
Closed -$476K
SBUX icon
450
Starbucks
SBUX
$118B
-3,576
Closed -$209K

Similar funds

Advisory Research's Q3 2017 Portfolio in Review

As of Q3 2017, Advisory Research held 498 positions worth $6.28B, down 0.94% from $6.34B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Advisory Research's Q3 2017 filing shows 72 new, 148 increased, 175 reduced and 71 closed positions. Its largest new stake was Anadarko Petroleum Corporation: 1,567,067 shares worth $62.1M. The largest sale was Oneok Partners LP, an estimated $55.7M.

By sector, the portfolio is most concentrated in Energy at 51% of assets, down from 53% a quarter earlier, followed by Financials and Industrials.

  • Advisory Research's largest Q3 2017 buy was Anadarko Petroleum Corporation: 1,567,067 shares worth $62.1M.
  • Advisory Research added most to Oneok in Q3 2017, an estimated $34.1M increase.
  • Advisory Research's biggest Q3 2017 reduction was Brink's, cutting an estimated $32M.
  • Advisory Research fully exited Oneok Partners LP in Q3 2017, selling an estimated $55.7M.
  • Advisory Research's ten largest holdings make up 28% of its $6.28B portfolio in Q3 2017.
  • Advisory Research opened 72 new positions and closed 71 in Q3 2017.
  • Advisory Research's portfolio value fell 0.94% quarter-over-quarter to $6.28B.

Based on Advisory Research's 13F filing for Q3 2017, filed 14 Nov 2017.